Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Apr 14;11(4):e043266.
doi: 10.1136/bmjopen-2020-043266.

Short-term morbidity and mortality following radical cystectomy: a systematic review

Sophia Liff Maibom  1   2 , Ulla Nordström Joensen  3   2 , Alicia Martin Poulsen  4 , Henrik Kehlet  2   5 , Klaus Brasso  3 , Martin Andreas Røder  3   2
Affiliations

Short-term morbidity and mortality following radical cystectomy: a systematic review

Sophia Liff Maibom et al. BMJ Open. .

Abstract

Objective: To study short-term (<90 days) morbidity and mortality following radical cystectomy (RC) for bladder cancer and identify modifiable risk factors associated with these.

Design: Systematic review.

Methods: The systematic review was conducted according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. PubMed and EMBASE were searched for relevant papers on 11 June 2019 and rerun on 27 May 2020. Studies reporting complications, reoperations, length of stay and mortality within 90 days were included. Studies were reviewed according to criteria from the Oxford Centre for Evidence-Based Medicine and the quality of evidence was assessed using the Newcastle-Ottawa Scale.

Results: The search retrieved 1957 articles. Sixty-six articles were included. The quality of evidence was poor to good. Most studies were retrospective, and no randomised clinical trials were identified. Of included studies a median of 6 Martin criteria for reporting complications after surgery were fulfilled. The Clavien-Dindo classification for grading complications was most frequently used. The weighted overall complication rate after RC was 34.9% (range 28.8-68.8) for in-house complications, 39.0% (range 27.3-80.0) for 30-day complications and 58.5% (range 36.1-80.5) for 90-day complications. The most common types of complications reported were gastrointestinal (29.0%) and infectious (26.4%). The weighted mortality rate was 2.4% (range 0.9-4.7) for in-house mortality, 2.1% (0.0-3.7) for 30-day mortality and 4.7% (range 0.0-7.0) for 90-day mortality. Age and comorbidity were identified as the best predictors for complications following RC.

Conclusion: Short-term morbidity and mortality are high following RC. Reporting of complications is heterogeneous and the quality of evidence is generally low. There is a continuous need for randomised studies to address any intervention that can reduce morbidity and mortality following RC.

Prospero registration number: 104937.

Keywords: bladder disorders; surgery; urological tumours.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

Figures

Figure 1
Figure 1
Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) flow chart. From: Moher D et al.
See this image and copyright information in PMC

References

    1. Alfred Witjes J, Lebret T, Compérat EM, et al. Updated 2016 EAU guidelines on muscle-invasive and metastatic bladder cancer. Eur Urol 2017;71:462–75. 10.1016/j.eururo.2016.06.020 - DOI - PubMed
    1. Moher D, Shamseer L, Clarke M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev 2015;4:1. 10.1186/2046-4053-4-1 - DOI - PMC - PubMed
    1. Covidence . Covidence systematic review software [Internet]. Veritas Health Innovation Ltd, Melbourne, Australia. Available: www.covidence.org
    1. Martin RCG, Brennan MF, Jaques DP. Quality of complication reporting in the surgical literature. Ann Surg 2002;235:803–13. 10.1097/00000658-200206000-00007 - DOI - PMC - PubMed
    1. Howick J, Chalmers I, Glasziou P. The Oxford 2011 levels of evidence”. Oxford centre for evidence-based medicine. [Internet]. Available: http://www.cebm.net/index.aspx?o=5653

Publication types